PURE Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. PURE’s patented technology platform is based on patented stabilized ionic silver; its initial products contain silver dihydrogen citrate (SCC), a broad-spectrum, non-toxic antimicrobial agent which offers 24-hour residual protection and formulates well with other compounds. SDC-based disinfecting and sanitizing products are registered by the EPA. For more information, visit the company’s website at www.purebio.com